H7S-22069-89852
1 vaccination
2 coded responses
13 check-ins
2 free-text entries
1 call case
- Sex
- Female
- Age at first dose
- 31-35
- ZIP prefix
- 900 / CA
- Registered
- 2021-03-02
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-03-02
Registered in v-safe
-
2021-03-02
Dose 1 — Pfizer-BioNTech
- 2021-03-02
- 2021-03-04
- 2021-03-05
- 2021-03-06
- 2021-03-07
- 2021-03-08
- 2021-03-09
- 2021-03-16
- 2021-03-23
- 2021-03-30
-
2021-06-03
Survey response — 3 months, dose 1MedDRA: Nasopharyngitis — Feeling: GoodFree text: ColdMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2021-09-02
-
2022-03-02
Survey response — 12 months, dose 1MedDRA: COVID-19 — Feeling: Good · Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Outpatient clinic or urgent care clinic visitFree text: CovidMedDRA releases: 2024-11 · check-in free text available
-
2022-03-02
Report sent to call center — 12 months, dose 1Be unable to do your normal daily activities · Get care from a doctor or other healthcare professionalOutpatient clinic or urgent care clinic visit · 1 call case(s)
- 2022-03-03
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-03-02 | Pfizer-BioNTech |
Call center
1 call center case
1 unsuccessful
Free text
Release 8 — 3 months, dose 1
Symptoms: Cold
Release 11 — 12 months, dose 1
Symptoms: Covid
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | COVID-19 | · | · | ✓ |
| SD | Nasopharyngitis | ✓ | ✓ | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release